PMA P240037

Device
VENTANA MET (SP44) RxDx Assay
Applicant
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)
Product code
SER
Decision date
2026-10-23
Generic name
Immunohistochemistry Assay, Antibody, MET
Approval order statement
Approval to update the labeling for the VENTANA MET (SP44) RxDx Assay to include results of supplemental data provided in the Post-Approval Study (PAS) Report P240037/R004 for utilization of SurePath for preparation of cytology specimens.

Current openFDA PMA Record#

Device
VENTANA MET (SP44) RxDx Assay
Applicant
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)
PMA number
P240037
Supplement
S003
Product code
SER
Generic name
Immunohistochemistry Assay, Antibody, MET
Decision date
2026-10-23
Decision code
APPR
Date received
2026-08-12
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Approval order statement
Approval to update the labeling for the VENTANA MET (SP44) RxDx Assay to include results of supplemental data provided in the Post-Approval Study (PAS) Report P240037/R004 for utilization of SurePath for preparation of cytology specimens.